alexa Diffuse Large B-cell Lymphoma: Treatment And Monitoring Advances In The Molecular Era
ISSN: 2155-9864

Journal of Blood Disorders & Transfusion
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on Hematology & Blood Disorders
September 29-October 01, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Mark Roschewski
Keynote: J Blood Disorders Transf
DOI: 10.4172/2155-9864.S1.005
Abstract
Diffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell non-Hodgkin?s lymphoma (NHL) affecting patients of all ages with a wide range of clinical presentations. Even though DLBCL is curable in advanced stages, up to one-third of patients will not achieve cure with initial therapy. In the modern era of rituximab-containing therapy given as initial treatment, the prognosis for patients who require salvage therapy is poor and most of them will eventually succumb to their disease. Insight into the complex molecular circuitry of DLBCL reveals a diverse range of somatic mutations and aberrant intracellular signaling pathways that characterize distinct molecular subsets. The next major breakthrough in DLBCL therapy during this ?molecular era? of disease definition will be identification of combinations of novel agents that target the oncogenic drivers of these DLBCL subsets. Results from recent landmark clinical trials with translational molecular investigations will be presented in the context of advancement towards precision medicine. Additional data regarding molecular monitoring of DLBCL after therapy will also be presented.
Biography
Mark Roschewski received his BA from the University of Notre Dame in 1997 and MD from the University of Nebraska Medical Center in 2001. He completed his Hematology-Oncology Fellowship in 2009 at Walter Reed Army Medical Center (WRAMC) in Washington DC, where he served as the Director of Hematologic Diseases at WRAMC for 3 years. He joined the Center for Cancer Research at the NCI in 2013 where his current role is as an Associate Clinical Investigator in the Lymphoid Malignancies Branch with research focused on aggressive lymphomas and multiple myeloma.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords